Literature DB >> 20401964

Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.

Tatsuya Kikuchi1, Toshimitsu Okamura, Takuya Arai, Takayuki Obata, Kiyoshi Fukushi, Toshiaki Irie, Tetsuya Shiraishi.   

Abstract

BACKGROUND AND
PURPOSE: Cholinesterase inhibitors have been widely used for the treatment of patients with dementia. Monitoring of the cholinesterase activity in the blood is used as an indicator of the effect of the cholinesterase inhibitors in the brain. The selective measurement of cholinesterase with low tissue dilution is preferred for accurate monitoring; however, the methods have not been established. Here, we investigated the effect of tissue dilution on the action of cholinesterase inhibitors using a novel radiometric method with selective substrates, N-[(14)C]methylpiperidin-4-yl acetate ([(14)C]MP4A) and (R)-N- [(14)C]methylpiperidin-3-yl butyrate ([(14)C]MP3B_R), for AChE and butyrylcholinesterase (BChE) respectively. EXPERIMENTAL APPROACH: We investigated the kinetics of hydrolysis of [(14)C]-MP4A and [(14)C]-MP3B_R by cholinesterases, and evaluated the selectivity of [(14)C]MP4A and [(14)C]MP3B_R for human AChE and BChE, respectively, compared with traditional substrates. Then, IC(50) values of cholinesterase inhibitors in minimally diluted and highly diluted tissues were measured with [(14)C]MP4A and [(14)C]MP3B_R. KEY
RESULTS: AChE and BChE activities were selectively measured as the first-order hydrolysis rates of [(14)C]-MP4A and [(14)C]MP3B_R respectively. The AChE selectivity of [(14)C]MP4A was an order of magnitude higher than traditional substrates used for the AChE assay. The IC(50) values of specific AChE and BChE inhibitors, donepezil and ethopropazine, in 1.2-fold diluted human whole blood were much higher than those in 120-fold diluted blood. In addition, the IC(50) values of donepezil in monkey brain were dramatically decreased as the tissue was diluted. CONCLUSIONS AND IMPLICATIONS: This method would effectively monitor the activity of cholinesterase inhibitors used for therapeutics, pesticides and chemical warfare agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401964      PMCID: PMC2925496          DOI: 10.1111/j.1476-5381.2010.00674.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.

Authors:  T Kosasa; Y Kuriya; K Matsui; Y Yamanishi
Journal:  Eur J Pharmacol       Date:  2000-02-18       Impact factor: 4.432

3.  A simple, rapid, and quantitative radiometric assay of acetylcholinesterase.

Authors:  M K Lewis; M E Eldefrawi
Journal:  Anal Biochem       Date:  1974-02       Impact factor: 3.365

Review 4.  RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

Authors:  J J Sramek; N R Cutler
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Oct-Dec       Impact factor: 2.703

5.  Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.

Authors:  Valtteri Kaasinen; Kjell Någren; Tarja Järvenpää; Anne Roivainen; Meixiang Yu; Vesa Oikonen; Timo Kurki; Juha O Rinne
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

6.  Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET.

Authors:  Anne Roivainen; Juha Rinne; Jere Virta; Tarja Järvenpää; Satu Salomäki; Miexiang Yu; Kjell Någren
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

7.  Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal function.

Authors:  Christa F Nagy; Dinesh Kumar; Edward I Cullen; W Kline Bolton; Thomas C Marbury; Maria J Gutierrez; H Wayne Hutman; Raymond D Pratt
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

8.  Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

Authors:  M Iyo; H Namba; K Fukushi; H Shinotoh; S Nagatsuka; T Suhara; Y Sudo; K Suzuki; T Irie
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

9.  A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals.

Authors:  A C Nostrandt; J A Duncan; S Padilla
Journal:  Fundam Appl Toxicol       Date:  1993-08

10.  Comparison of methods used for the determination of cholinesterase activity in whole blood.

Authors:  Ramachandra S Naik; Bhupendra P Doctor; Ashima Saxena
Journal:  Chem Biol Interact       Date:  2008-05-07       Impact factor: 5.192

View more
  1 in total

1.  Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia.

Authors:  Yoshinori Haraguchi; Yoshito Mizoguchi; Masahiro Ohgidani; Yoshiomi Imamura; Toru Murakawa-Hirachi; Hiromi Nabeta; Hiroshi Tateishi; Takahiro A Kato; Akira Monji
Journal:  J Neuroinflammation       Date:  2017-12-22       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.